BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 398991)

  • 1. Prostaglandin I2 partially inhibits human platelet aggregation stimulated by antithymocyte globulin.
    Freeman A; Thomas J; Thomas F; Ellis EF
    Prostaglandins Med; 1979 Oct; 3(4):211-3. PubMed ID: 398991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antithymocyte globulin and other immune reactants on human platelets.
    Rosenberg JC; Lekas N; Lysz K; Morrell R
    Surgery; 1975 Apr; 77(4):520-9. PubMed ID: 1096340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV; Ayer DE; Gorman RR
    Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of platelets with aortic subendothelium: inhibition of adhesion and secretion by prostaglandin I2.
    Adelman B; Stemerman MB; Mennell D; Handin RI
    Blood; 1981 Aug; 58(2):198-205. PubMed ID: 7018620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release, aggregation and lysis of human platelets by antilymphocyte globulin and antiplatelet serum.
    Lekas N; Rosenberg JC
    Thromb Haemost; 1976 Nov; 36(2):411-23. PubMed ID: 1087479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prostaglandin-dependent immunoregulatory mechanism activated by in vivo administration of antithymocyte globulin.
    Thomas JM; Carver FM; Fahrenbruch GB; Hall WR; Deepe RM; Thomas FT
    Surgery; 1983 Aug; 94(2):384-91. PubMed ID: 6224306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
    Rosenberg JC; Sell T
    Transplantation; 1975 Oct; 20(4):346-50. PubMed ID: 169611
    [No Abstract]   [Full Text] [Related]  

  • 11. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
    Rudd MA; George D; Amarante P; Vaughan DE; Loscalzo J
    Circ Res; 1990 Nov; 67(5):1175-81. PubMed ID: 2146037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin I2 on platelet adhesion.
    Fésüs L; Hársfalvi J; Kovács E; Muszbek L; Stadler I
    Biomaterials; 1981 Jan; 2(1):53-4. PubMed ID: 7016206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is prostacyclin a physiologically important circulating anti-platelet agent?
    Steer ML; MacIntyre DE; Levine L; Salzman EW
    Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S; Nieuweboer B; Matthes S; Schillinger E
    Prog Clin Biol Res; 1989; 301():365-9. PubMed ID: 2477855
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets.
    Nolte C; Eigenthaler M; Schanzenbächer P; Walter U
    Biochem Pharmacol; 1991 Jul; 42(2):253-62. PubMed ID: 1713458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandins and platelet aggregation.
    Smith JB
    Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.